http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004115264-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
filingDate 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750a7f734fc7dc93cfedfc972b789034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45e0c08ba3145387779a20e528b128cb
publicationDate 2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004115264-A1
titleOfInvention Fenofibrate tablets
abstract The invention concerns a novel galenic formulation of fenofibrate for oral administration and its method of preparation. The invention is characterised in that it consists of a tablet obtained by compressing a mixture comprising: a) a granular material containing: 1 to 5% of a surfactant, micronized fenofibrate, at least a solid support selected among starch, cellulose or their derivatives, except C 12 disaccharides; said granular material being obtained by granulating the mixture using an aqueous polyvinylpyrrolidone solution; b) crosslinked polyvinylpyrrolidone; c) optionally flow or lubricating agents, the amount of fenofibrate being more than 50 wt. %, expressed relative to the tablet weight. The invention is useful for treating hypercholesterolemia and hypertriglyceridemia.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007122471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010278922-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006177499-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9060932-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8936786-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010297245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9949924-B2
priorityDate 2001-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6042847-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6074670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7101574-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827536-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5776495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4895726-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6277405-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128483776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420709326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128633517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129818107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405584
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID687084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID687084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11557370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406563

Total number of triples: 71.